The survival analysis demonstrated that positive margin status, larger tumor size, positive lymph nodes, distant metastasis, hormone receptor status (ER-negative, PR-negative), higher tumor stage, and two of the PAM50 subtypes (Basal and Her2) significantly contributed to disease progression. This evidence concerns the gene ESR1 and neoplasm.